News

Verisk Analytics Reports Stellar Results for Third Quarter

Verisk Analytics Reports Stellar Results for Third Quarter

Impressive Financial Performance from Verisk Analytics

Verisk Analytics, Inc. recently announced its financial performance for the third quarter of 2024, showcasing a remarkable growth trajectory. The company reported consolidated revenues of $725 million, a 7.0% increase compared to the previous year, and a 6.8% rise on an organic constant currency (OCC) basis. This significant growth underscores the strength of Verisk's subscription-based business model, positioning it as a leading data analytics provider in the insurance industry.

Strong Income and Cash Flow Results

During this quarter, income from continuing operations surged to $220 million, reflecting a 17.4% increase. Adjusted EBITDA, a non-GAAP measure recognized for highlighting operational performance, also rose to $401 million, marking a 9.4% increase and offering a 54.6% adjusted EBITDA margin for the trailing twelve months. Notably, the net cash generated from operating activities reached $296 million, representing an 18.4% year-over-year growth. Free cash flow amounted to $241 million, demonstrating Verisk's efficiency and commitment to returning value to shareholders.

Dividend and Share Repurchase Initiatives

Verisk’s Board of Directors has announced a cash dividend of 39 cents per share, scheduled for distribution on December 31, 2024. This dividend reflects an impressive 15% increase from last year, showcasing the company’s robust financial health and focus on returning capital to its investors. Additionally, during the third quarter, Verisk executed a $400 million accelerated share repurchase program, resulting in the repurchase of over 1.5 million shares at an average price of $263.92.

Strategic Initiatives Supporting Growth

Lee Shavel, the president and CEO of Verisk, emphasized the effective strategic dialogues that foster stronger relationships and generate new opportunities within their client base. This quarter proved pivotal as they continued to innovate and invest significantly in enhancing operational efficiencies within the insurance sector. Verisk's commitment to technological advancement amidst various challenges faced by the industry was also highlighted, showcasing the company's proactive approach to ensuring growth and profitability.

Driving Growth Through Subscription Services

Verisk's growth is largely attributed to the increasing strength in its subscription services. The OCC revenue rose by 6.8%, primarily driven by sequential improvements in underwriting and claims processes. Strong performance was noted within both the underwriting and claims segments, bolstered by a focus on anti-fraud solutions and enhanced service delivery. The investment in technological innovation continues to position Verisk as a key partner for clients navigating the complexities of the insurance landscape.

Looking Ahead: Financial Guidance for 2024

Looking forward, Verisk remains optimistic about its growth pathways. The company maintains its financial outlook for 2024, projecting revenues between $2.84 billion and $2.9 billion, with anticipated adjusted EBITDA of approximately $1.54 billion to $1.6 billion. This guidance indicates a consistent approach to operational excellence and sustained profit generation as it adapts to market dynamics.

Frequently Asked Questions

What were Verisk's total revenues for Q3 2024?

Verisk reported total revenues of $725 million for the third quarter of 2024, representing a 7.0% increase year-over-year.

How much was the cash dividend declared by Verisk?

The Board approved a cash dividend of 39 cents per share, reflecting a 15% increase from the previous year's distribution.

What is the reason behind the increase in income from continuing operations?

The increase to $220 million, up 17.4%, was driven by strong revenue growth and effective cost management.

How did Verisk's share repurchase program impact its earnings?

During Q3 2024, Verisk repurchased $400 million worth of shares, which contributed to a lower average share count, positively impacting earnings per share.

What is the focus of Verisk's strategic initiatives?

Verisk's strategic initiatives focus on enhancing operational efficiency, client engagement, and innovation within the insurance sector to address emerging challenges.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Peptide Therapy Rules Change: Gameday Ups the Ante

Updated Category News Views 110

Gameday Men's Health: Leading the Safe Peptide Charge Finally, we got some regulatory sanity stepping up to the plate with peptides. You see, the FDA's new interim policy is letting state-licensed compounding pharmacies work their magic with peptides, but only under strict medical watch. And Gameday Men's Health sure ain't wasting any time setting up shop in this fresh...

Continue Reading
Fidelis Care Opens $120K Workforce Grants for Aid

Updated Category News Views 112

Fidelis Care Steps Up Workforce Engagement Fidelis Care's latest move introduces a fresh shot at tackling two birds with one stone—economic and health stability for Medicaid members. The Workforce Pathways to Health and Economic Mobility grants present up to $120,000 in support for New Yorkers, an attempt aimed squarely at reducing the vicious cycle that traps many in...

Continue Reading
Chip Earnings Fuel Market Gains Amid Volatility Dip

Updated Category News Views 56

Tech Earnings Drive Market Resilience Amid a climate of economic uncertainty, it's refreshing to see semiconductor and tech earnings offering a little backbone to the market. This week, the S&P 500 climbed 1.51%, while the Nasdaq Composite jumped 1.98% over three sessions. It's like watching Rocky get up off the mat—those indices pushing higher when it seemed like they...

Continue Reading
Read/Write Labs Tackles Brain-Tech Fusion Ambitions

Updated Category News Views 88

Buck up, investors! There's a new player on the field marrying AI and neuroscience with some serious firepower and a respectable roster. Read/Write Labs—what you might've known yesterday as Dandelion Science—has kicked off under a fresh banner, amping up efforts to decode and recode our noggin's electrical orchestra. And with the likes of Jim DiCarlo, Dan Yamins, and...

Continue Reading
Fannie Mae Q3 2026 Earnings Surpass Expectations

Updated Category News Views 84

An Upward Trend in Fannie Mae's Financials Hold onto your hats—Fannie Mae's swinging into action with hefty third-quarter numbers that'd make most firms drool. The latest figures, disclosed in their 10-Q filing, boast a net income of $4.2 billion for Q3 2026. You heard me right, billion! Now, to a market vet, these aren't digits to scoff at. And as the economy keeps...

Continue Reading
Aktia Bank: Steady Ratings, Focused Expansion in Europe

Updated Category News Views 123

Aktia's Ratings Get a Boost In the world of financial minutiae, it was S&P Global Ratings that took the stage, buzzing about Aktia Bank Plc. The bank just had its ratings held steady with an outlook lift from negative to stable. That's like someone throwing you a life jacket when you're treading water; significant if you're trying to stay afloat, not so much if you've got...

Continue Reading
ESENTIA Lifts EBITDA, Reduces Debt, Eyes Expansion

Updated Category News Views 38

ESENTIA Flexes Financial Muscles: What's the Deal? Walk with me through the gritty world of financials, and you’ll see that ESENTIA’s latest figures are a mixed bag with a tantalizing upside. We're talking about adjusted EBITDA ticking up to a cool $86 million in the third quarter of '26, a 1.3% lift from last year. Not too shabby, eh? Especially when you're grappling...

Continue Reading
VeriSilicon's GLTiny: Game-Changer for Wearable Tech

Updated Category News Views 45

Revolutionizing Wearable Graphics with GLTiny There's a fresh breeze blowing through the world of wearable tech, and VeriSilicon's GLTiny seems to be at the heart of it. When the silicon giant out of Shanghai tossed GLTiny into the mix, it wasn't just throwing another chip on the barbie. Oh no, this is a real pivot towards juicing up those smart gadgets strapped to your...

Continue Reading
Ballard’s HPU Agile-H Poised to Transform Portable Energy

Updated Category News Views 76

Another Step Forward with Hydrogen Ballard's got another ace up its sleeve with the HPU Agile-H. Now here’s the kicker—everyone’s scrambling for cleaner, more portable energy solutions, and Ballard’s stepped up. Born from their acquisition of GeoPura, this lightweight hydrogen powerhouse is engineered for those spots rudely ignored by the grid. Place your bets on...

Continue Reading
Replay Sports Cards Nets STAR Award for Innovation

Updated Category News Views 82

A New Era for Franchise Onboarding Just when you think the sports card world couldn't get any more niche, along comes Replay Sports Cards thumping its chest with some serious innovation. This Charlotte-based franchise just snagged the Franchise Innovation Award from Franchise Update Media. Yep, they're the only ones getting tips of the hat for the Most Innovative...

Continue Reading

Top 5 Most Recently Viewed Articles

Sollis Health Welcomes Katy Marshall as Chief Growth Officer

Updated Category News Views 511

Sollis Health Welcomes Katy Marshall as Chief Growth Officer The leading concierge medical provider has appointed Katy Marshall as Chief Growth Officer. With her extensive background in driving growth for consumer and healthcare brands, she will guide the company's marketing, sales, and product strategies. Experienced Leadership Katy brings a wealth of experience to...

Continue Reading
Kulicke & Soffa Delivers Strong Q4 Performance Highlights

Updated Category News Views 153

Strong Financial Performance in Q4 Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC) reported impressive financial results for the fourth quarter, showcasing resilience and growth in a challenging market. The company achieved a net revenue of $177.6 million, reflecting its ongoing commitment to innovation and operational efficiency. Lester Wong, the Interim Chief...

Continue Reading
Unlocking Dividend Income: Strategies for Salesforce Investors

Updated Category News Views 85

Understanding Salesforce's Dividend Potential Salesforce, Inc. (NYSE: CRM) is a leading company known for its innovative cloud-based solutions. With its upcoming fourth-quarter financial results, many investors are curious about how to maximize their returns, particularly through dividends. This approach can be an excellent way to create a significant income stream while...

Continue Reading
Investigation Launched into Sage Therapeutics' Recent Drug Trials

Updated Category News Views 93

Introducing Sage Therapeutics Sage Therapeutics, Inc. (NASDAQ: SAGE) is a biopharmaceutical company dedicated to developing innovative therapies aimed at enhancing brain health. However, recent events have raised serious concerns among investors, prompting an investigation into possible violations of federal securities laws. Stock Price Affected by Recent Events FDA...

Continue Reading
Genius Group Investors Can Pursue Class Action for Losses

Updated Category News Views 208

Genius Group Limited Faces Class Action Lawsuit Genius Group Limited, recognized by its ticker symbol GNUS, is currently embroiled in a class action lawsuit aimed at addressing significant investor losses. This legal action comes as a response to alleged stock market misconduct by certain trading firms. Investors Encouraged to Take Action The law firm Bronstein, Gewirtz &...

Continue Reading